These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 35499168

  • 1. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.
    Kommoss FKF, Chiang S, Köbel M, Koelsche C, Chang KT, Irving JA, Dickson B, Thiryayi S, Rouzbahman M, Rasty G, von Deimling A, Lee CH, Turashvili G.
    Am J Surg Pathol; 2022 Aug 01; 46(8):1142-1152. PubMed ID: 35499168
    [Abstract] [Full Text] [Related]

  • 2. Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications.
    Kommoss FK, Chang KT, Stichel D, Banito A, Jones DT, Heilig CE, Fröhling S, Sahm F, Stenzinger A, Hartmann W, Mechtersheimer G, Sinn HP, Schmidt D, Kommoss F, von Deimling A, Koelsche C.
    J Pathol Clin Res; 2020 Jul 01; 6(3):178-184. PubMed ID: 32352245
    [Abstract] [Full Text] [Related]

  • 3. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
    Mariño-Enriquez A, Lauria A, Przybyl J, Ng TL, Kowalewska M, Debiec-Rychter M, Ganesan R, Sumathi V, George S, McCluggage WG, Nucci MR, Lee CH, Fletcher JA.
    Am J Surg Pathol; 2018 Mar 01; 42(3):335-341. PubMed ID: 29200103
    [Abstract] [Full Text] [Related]

  • 4. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
    Lin DI, Hemmerich A, Edgerly C, Duncan D, Severson EA, Huang RSP, Ramkissoon SH, Connor YD, Shea M, Hecht JL, Ali SM, Vergilio JA, Ross JS, Elvin JA.
    Gynecol Oncol; 2020 May 01; 157(2):357-366. PubMed ID: 32156473
    [Abstract] [Full Text] [Related]

  • 5. Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas.
    Lin DI, Huang RSP, Mata DA, Decker B, Danziger N, Lechpammer M, Hiemenz M, Ramkissoon SH, Ross JS, Elvin JA.
    Mod Pathol; 2021 Dec 01; 34(12):2200-2210. PubMed ID: 34302054
    [Abstract] [Full Text] [Related]

  • 6. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
    Cotzia P, Benayed R, Mullaney K, Oliva E, Felix A, Ferreira J, Soslow RA, Antonescu CR, Ladanyi M, Chiang S.
    Am J Surg Pathol; 2019 May 01; 43(5):662-669. PubMed ID: 30789359
    [Abstract] [Full Text] [Related]

  • 7. Uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions: Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior.
    Devins KM, Attygalle AD, Croce S, Vroobel K, Oliva E, McCluggage WG.
    Am J Surg Pathol; 2023 Jun 01; 47(6):717-724. PubMed ID: 37032555
    [Abstract] [Full Text] [Related]

  • 8. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.
    Chiang S, Lee CH, Stewart CJR, Oliva E, Hoang LN, Ali RH, Hensley ML, Arias-Stella JA, Frosina D, Jungbluth AA, Benayed R, Ladanyi M, Hameed M, Wang L, Kao YC, Antonescu CR, Soslow RA.
    Mod Pathol; 2017 Sep 01; 30(9):1251-1261. PubMed ID: 28621321
    [Abstract] [Full Text] [Related]

  • 9. JAZF1, YWHAE and BCOR gene translocation in primary extrauterine low-grade and high-grade endometrial stromal sarcomas.
    Sun L, Zhao W, Zhao Z, Zhu Y.
    Histopathology; 2022 Apr 01; 80(5):809-819. PubMed ID: 34843125
    [Abstract] [Full Text] [Related]

  • 10. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity.
    Lewis N, Soslow RA, Delair DF, Park KJ, Murali R, Hollmann TJ, Davidson B, Micci F, Panagopoulos I, Hoang LN, Arias-Stella JA, Oliva E, Young RH, Hensley ML, Leitao MM, Hameed M, Benayed R, Ladanyi M, Frosina D, Jungbluth AA, Antonescu CR, Chiang S.
    Mod Pathol; 2018 Apr 01; 31(4):674-684. PubMed ID: 29192652
    [Abstract] [Full Text] [Related]

  • 11. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
    Momeni-Boroujeni A, Mohammad N, Wolber R, Yip S, Köbel M, Dickson BC, Hensley ML, Leitao MM, Antonescu CR, Benayed R, Ladanyi M, Lee CH, Chiang S.
    Mod Pathol; 2021 May 01; 34(5):1008-1016. PubMed ID: 33077922
    [Abstract] [Full Text] [Related]

  • 12. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis.
    Alkanat NE, Uner A, Usubutun A.
    Int J Surg Pathol; 2023 Aug 01; 31(5):521-531. PubMed ID: 35506912
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic Value of Combined BCOR, Cyclin D1, and CD10 in Differentiating Endometrial Stromal Sarcoma From Other Uterine Spindle Cell Lesions.
    Abouelkhair MB, Shakweer MM, Faisal MM, Nasreldin MH, Farid LM.
    Appl Immunohistochem Mol Morphol; 2024 Aug 01; 32(7):326-335. PubMed ID: 38961542
    [Abstract] [Full Text] [Related]

  • 14. ZC3H7B-BCOR Fusion High-grade Endometrial Stromal Sarcoma With Morphologic Features of Low-grade Endometrial Stromal Sarcoma. A Case Report and Review of Literature.
    Zhao L, Cheng YW, Policarpio-Nicolas MLC.
    Int J Gynecol Pathol; 2023 Nov 01; 42(6):597-601. PubMed ID: 37562066
    [Abstract] [Full Text] [Related]

  • 15. ZC3H7B-BCOR-Rearranged Endometrial Stromal Sarcomas: A Distinct Subset Merits its Own Classification?
    Mansor S, Kuick CH, Lim SL, Quek R, Wong APC, Lim-Tan SK, Lim TYK, Chang KTE.
    Int J Gynecol Pathol; 2019 Sep 01; 38(5):420-425. PubMed ID: 29901520
    [Abstract] [Full Text] [Related]

  • 16. Breast metastasis in high-grade endometrial stromal sarcoma (HG-ESS) with BCOR rearrangement: a case report of a novel metastatic site.
    Fong A, Offman S.
    Diagn Pathol; 2023 Mar 02; 18(1):34. PubMed ID: 36864468
    [Abstract] [Full Text] [Related]

  • 17. Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma.
    Kang N, Zhang Y, Guo S, Chen R, Kong F, Wang S, Yuan M, Chen R, Shen D, Wang J.
    Cancer Res Treat; 2023 Jul 02; 55(3):978-991. PubMed ID: 36731460
    [Abstract] [Full Text] [Related]

  • 18. Novel EPC1 gene fusions in endometrial stromal sarcoma.
    Dickson BC, Lum A, Swanson D, Bernardini MQ, Colgan TJ, Shaw PA, Yip S, Lee CH.
    Genes Chromosomes Cancer; 2018 Nov 02; 57(11):598-603. PubMed ID: 30144186
    [Abstract] [Full Text] [Related]

  • 19. High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalities.
    Zou Y, Turashvili G, Soslow RA, Park KJ, Croce S, McCluggage WG, Stewart CJR, Oda Y, Oliva E, Young RH, Da Cruz Paula A, Dessources K, Ashley CW, Hensley ML, Yip S, Weigelt B, Benayed R, Antonescu CR, Lee CH, Chiang S.
    Mod Pathol; 2020 Sep 02; 33(9):1861-1870. PubMed ID: 32317704
    [Abstract] [Full Text] [Related]

  • 20. Highly Invasive and Metastatic High-grade Endometrial Stromal Sarcoma With BCOR Gene Alterations: A Case Report.
    Ling F, Ruan S, Chen H, Xiong X, Zhao D, Haybaeck J, Zhang C.
    In Vivo; 2022 Sep 02; 36(4):1971-1976. PubMed ID: 35738637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.